HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Activist Investor May Urge P&G To Lose Non-Core Brands, McDonald

This article was originally published in The Rose Sheet

Executive Summary

Changes may be ahead for Procter & Gamble following William Ackman and Pershing Square Capital Management’s investment in the Cincinnati-based consumer-goods giant. Analysts suggest the activist investor may push to replace CEO Bob McDonald and divest non-core brands.

You may also be interested in...

Inside The Coty/P&G Beauty Mega Deal

Coty faced off against 44 other interested parties last year to eventually win P&G's beauty business with its $12.5bn merger bid, ushering it to the top tier of the global beauty industry. An April 22 SEC filing offers inside details on Coty and P&G's businesses and how the deal came together.

Lafley Returns To P&G Helm As McDonald’s Tenure Ends After Four Years

Procter & Gamble turns to its former leader, who was replaced by Bob McDonald in 2009, after facing investor and analyst pressure to shake up management. Lafley’s return as CEO “provides us with new hope,” one market analyst says.

P&G Looks To “Transform” Categories, But Ackman Presses For Results

CFO Jon Moeller says product launches will make “obsolete our existing categories and transform them in ways that create competitive advantage” for the firm. Activist investor Bill Ackman, however, says P&G is “vastly under-earning relative to its intrinsic earnings power.”

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts